LiverAce™: Detect Liver Injury Earlier and with Greater Confidence
Go beyond the limitations of ALT/AST. Our LiverAce™ Research-Use-Only overcomes the lag of traditional enzymes and the biases of PCR to deliver a true "Fail-Fast" capability. By merging molecular precision with immunoassay simplicity, we empower researchers in Pharma, Biotech and CROs to make critical Go/No-Go decisions with absolute confidence.
A Solution for Every Research Need
Whether you need rapid, specific screening, or a multi-omic validation, LiverAce™ secures your data integrity.
The Destina Advantage: Elevating Data Integrity
Early Detection
Identify hepatocellular injury hours before traditional ALT/AST enzymes.
Superior Specificity
miR-122 eliminates false positives from muscle or other tissue damage.
IsomiR Precision
Capture the total molecular signature of miR-122 isomiRs, where PCR fails.
Immunoassay Protocol
Merge molecular and immunoassay workflows into a single reaction well.
Data-Driven Insights
Visually understand the superior performance and biological rationale behind our LiverAce™ biomarkers.
Adapted from: Chowdhary V et al. Am J Pathol. 2017 Dec;187(12):2758-2774.
Adaptaded from: López-Longarela et al. Anal Chem. 2020 Feb;18,92(4):3388-3395
Adaptaded from: Jopling C. RNA Biol. 2012 Feb 1;9(2):137–142.
Resources & Publications
User Guides
Request the complete, detailed protocols for the LiverAce™ kits.
Key Publications
Clinical evidence supporting miR-122 and Keratin-18.
Technology Foundational
Papers on Dynamic Chemical Labelling (DCL).
Ready to Transform Your Liver Safety Assessment?
Biomarker Rise After Insult
Simple, Streamlined, Superior Protocol
1. Add Sample
2. Hybridize
3. Label
4. Read